Almogril 6.25 mg Tablet belongs to a class of drugs known as 'antimigraine' used to prevent migraine symptoms such as headache, nausea, and vomiting. Migraine is a neurological condition characterized by intense pulsating, throbbing, pounding, debilitating headache, which usually occurs on one side of the head; however, it can occur on both sides or shift. Hormonal changes, stress, bright lights, loud sounds, and certain foods and drinks can trigger migraine headaches. 

Almogril 6.25 mg Tablet contains Zolmitriptan. It works by acting on the serotonin (5-HT) receptors located in the brain, thereby causing the narrowing of the brain's blood vessels, which affects the blood flow patterns associated with headaches. Thus, Almogril 6.25 mg Tablet helps effectively in treating symptoms of migraine-like headache, nausea and vomiting. 

Take Almogril 6.25 mg Tablet as prescribed by your doctor. Depending upon your medical condition, you are advised to take Almogril 6.25 mg Tablet for as long as your doctor has prescribed it for you. In some cases, you may experience certain common side effects such as dizziness, sleepiness, nausea, chest discomfort, dry mouth, irregular heartbeats and heartburn. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if you experience these side effects persistently. 

Do not take Almogril 6.25 mg Tablet if you are pregnant or breastfeeding unless prescribed. Almogril 6.25 mg Tablet should not be taken during the third trimester of pregnancy. Almogril 6.25 mg Tablet can increase the risk of fatal heart attack or stroke, gastrointestinal bleeding, ulceration and perforation of the stomach and intestines. Almogril 6.25 mg Tablet causes drowsiness and dizziness, so drive with caution. Almogril 6.25 mg Tablet should not be given to children as safety and efficacy have not been established. Avoid consuming alcohol along with Almogril 6.25 mg Tablet as it could lead to increased drowsiness and dizziness. Keep your doctor informed about your health condition and medicines to rule out any side effects.

Almogril 6.25 mg Tablet contains Zolmitriptan (anti-migraine medication), which prevents migraine symptoms such as headaches, nausea and vomiting. It works by acting on the serotonin (5-HT) receptors in the brain, thereby causing the narrowing of the brain's blood vessels, which affects the blood flow patterns associated with headaches. Thus, Almogril 6.25 mg Tablet  helps effectively in treating migraine symptoms like headache, nausea and vomiting. 

• Dizziness
• Sleepiness
• Nausea
• Vomiting
• Diarrhoea
• Feeling weak
• Chest discomfort
• Dry mouth
• Irregular heartbeats
• Heartburn

Do not take Almogril 6.25 mg Tablet if you are allergic to any of its contents, if you have had any recent heart surgery or stroke, blood circulation problems, heart problems, narrowing of blood vessels to the stomach, legs, arms or kidneys or uncontrolled high blood pressure. Be cautious as Almogril 6.25 mg Tablet can increase the risk of fatal heart attack or stroke, gastrointestinal bleeding, and ulceration. Do not take Almogril 6.25 mg Tablet if you are pregnant or breastfeeding unless prescribed. Almogril 6.25 mg Tablet should not be taken during the third trimester of pregnancy. Almogril 6.25 mg Tablet may cause drowsiness and dizziness, so drive only if you are alert. Almogril 6.25 mg Tablet should not be given to children as safety and effectiveness have not been established. Avoid consuming alcohol along with Almogril 6.25 mg Tablet as it could lead to increased drowsiness. Stop taking Almogril 6.25 mg Tablet and consult your doctor immediately if you have stomach pain or any signs of bleeding in the intestine or stomach, such as blood in stools.

Drug-Disease Interactions: Almogril 6.25 mg Tablet may interact with people with renal or liver problems, cardiovascular disease, heart failure, blood clots in the legs, gastrointestinal toxicity, mental illness, and Raynaud's disease (problems with blood flow).

Drug-Food Interactions: Avoid the consumption of alcohol, smoking and caffeinated products. Do not consume St John's Wort plant while taking Almogril 6.25 mg Tablet . 

Drug-Drug Interactions: Almogril 6.25 mg Tablet may have interaction with a blood thinner (warfarin, aspirin), cardiac glycoside (digoxin), anti-psychotic (lithium, alprazolam, escitalopram), anti-depressant (citalopram, duloxetine, fluoxetine, imipramine, nortriptyline), anti-hypertensive (propranolol, metoprolol), stomach ulcer medicine (cimetidine), pain killers (ibuprofen, naproxen).

• WARFARIN
• ASPIRIN
• DIGOXIN
• LITHIUM
• ALPRAZOLAM
• ESCITALOPRAM
• CITALOPRAM
• DULOXETINE
• FLUOXETINE
• IMIPRAMINE
• NORTRIPTYLINE
• PROPRANOLOL
• METOPROLOL
• CIMETIDINE
• IBUPROFEN
• NAPROXEN

• Perform meditation and yoga. This helps in relieving stress and provides relaxation. Follow a regular sleep pattern to improve the amount and quality of sleep you get. Massage your scalp to ease the pain. 
• Lie down in a quiet, dark room. Place a cold cloth over your forehead or neck. 
• Avoid smoking, alcohol and caffeinated drinks. Stay hydrated. Drink plenty of fluids. Maintaining a healthy diet and regular exercise helps improve overall health and boost self-esteem. 
• Learn what triggers your migraine and try avoiding them. Learn relaxation skills as they help in reducing stress. 
• Avoid bright lights, loud noise and extreme temperatures. 

• Constantly monitor your blood pressure while taking Almogril 6.25 mg Tablet .

Migraine: It is a neurological condition that is characterized by an intense, debilitating headache. Hormonal changes, stress, lack or excess of sleep, bright lights, loud sounds, and certain foods and drinks can trigger migraine headaches. Warning symptoms precede migraine headache one or two days before the headache itself. The warning symptoms include food cravings, depression, fatigue, hyperactivity, irritability and neck stiffness. Symptoms of migraine include throbbing pain in one area with varying intensity, nausea, vomiting, numbness or tingling sensation, difficulty speaking, and sensitivity to sound and light.